Advertisement News Archives - Pharmaceutical Business review
Pharmaceutical Business review is using cookies

ContinueLearn More
Close

News

November 29, 2023

Evommune, Accutar to discover drug candidates for chronic inflammatory diseases

Evommune has entered into a new strategic partnership with Accutar Biotechnology to discover new small-molecule drug candidates for chronic inflammatory diseases.

Evommune, Accutar to discover drug candidates for chronic inflammatory diseases